Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis

Background: Pediatric multiple sclerosis (MS) is rare: only 1.5–5% of MS cases are diagnosed before 18 years of age, and data on disease-modifying therapies (DMTs) for pediatric MS are limited. The CONNECTED study assessed the long-term safety and efficacy of treatment with delayed-release dimethyl...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Front Neurol
Hoofdauteurs: Alroughani, Raed, Huppke, Peter, Mazurkiewicz-Beldzinska, Maria, Blaschek, Astrid, Valis, Martin, Aaen, Gregory, Pultz, Joe, Peng, Xiaomei, Beynon, Vanessa
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2021
Onderwerpen:
Neurology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7812971/
https://ncbi.nlm.nih.gov/pubmed/33473248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.606418
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items